Cubist Systematic Strategies, LLC - BIOHAVEN PHARMACTL HLDG CO L ownership

BIOHAVEN PHARMACTL HLDG CO L's ticker is BHVN and the CUSIP is G11196105. A total of 287 filers reported holding BIOHAVEN PHARMACTL HLDG CO L in Q4 2021. The put-call ratio across all filers is 1.02 and the average weighting 0.8%.

Quarter-by-quarter ownership
Cubist Systematic Strategies, LLC ownership history of BIOHAVEN PHARMACTL HLDG CO L
ValueSharesWeighting
Q3 2022$565,000
-24.8%
3,740
-27.4%
0.00%
-40.0%
Q2 2022$751,000
-53.4%
5,154
-62.1%
0.01%
-64.3%
Q1 2022$1,611,000
+151.7%
13,586
+192.5%
0.01%
+133.3%
Q4 2021$640,000
-32.2%
4,645
-52.2%
0.01%
-45.5%
Q2 2021$944,000
+343.2%
9,727
+212.4%
0.01%
+266.7%
Q1 2021$213,000
-95.0%
3,114
-93.7%
0.00%
-94.8%
Q4 2020$4,251,000
+478.4%
49,597
+338.4%
0.06%
+427.3%
Q3 2020$735,000
+197.6%
11,313
+235.4%
0.01%
+175.0%
Q2 2020$247,000
-80.1%
3,373
-85.2%
0.00%
-82.6%
Q4 2019$1,241,000
+312.3%
22,800
+231.2%
0.02%
+283.3%
Q2 2019$301,000
+377.8%
6,884
+461.0%
0.01%
+200.0%
Q1 2019$63,000
-92.9%
1,227
-94.9%
0.00%
-95.2%
Q4 2018$891,000
+22.7%
24,089
+24.6%
0.04%
+5.0%
Q3 2018$726,000
+105.1%
19,339
+115.8%
0.04%
+122.2%
Q2 2018$354,000
+5.0%
8,963
-28.3%
0.02%0.0%
Q4 2017$337,000
+56.7%
12,492
+45.4%
0.02%
+28.6%
Q2 2017$215,0008,5920.01%
Other shareholders
BIOHAVEN PHARMACTL HLDG CO L shareholders Q4 2021
NameSharesValueWeighting ↓
Knoll Capital Management, LLC 896,844$123,594,00067.92%
RP Management, LLC 1,111,111$153,122,00064.09%
ORACLE INVESTMENT MANAGEMENT INC 2,075,402$286,011,00040.64%
ARS Investment Partners, LLC 463,392$63,860,0005.86%
KINGDON CAPITAL MANAGEMENT, L.L.C. 300,373$41,394,0004.76%
SILVERARC CAPITAL MANAGEMENT, LLC 80,348$11,073,0004.49%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 139,900$19,282,0004.30%
Avidity Partners Management LP 1,140,000$157,103,0003.33%
KINGDON CAPITAL MANAGEMENT, L.L.C. 200,000$27,562,0003.17%
Eventide Asset Management 1,635,000$225,319,0002.88%
View complete list of BIOHAVEN PHARMACTL HLDG CO L shareholders